I'll take $0.029 (without a 2 BB buyback)...that is definitely fine by me. The important thing is that those targets only factored in the confirmed $5MM infusion and if optimistically the buy back was 2BB shares. That doesn't include the realized revenues from Vortex, the unrealized revenues that will come from MaryGen, and the potential revenue from the sales out of the WA facility.